Prostate‐specific antigen testing by income, age, and region: a nationwide population‐based study

OBJECTIVE: To assess prostate-specific antigen (PSA) testing according to income, age, and region of residence in Sweden. PATIENTS AND METHODS: We conducted a nationwide, population-based open cohort study of men aged 40-90 years in Sweden without a prior diagnosis of prostate cancer between 2000 and 2023. The proportion of men that underwent at least one PSA test between 1 January and 31 December was estimated each year overall and stratified by income (bottom 25%, middle 50%, top 25%), age, and region of residence. RESULTS: The PSA testing was higher in the top income group across all ages. In 2019, prior to the coronavirus disease 2019 pandemic, overall PSA testing was 17% and ranged from 13% in the bottom income group to 20% in the top. Overall, PSA testing and income-related differences in PSA testing varied substantially between regions. In 2019, PSA testing varied between 12% and 20% between regions and difference in PSA testing between men with lowest and highest income ranged from 3.6% to 10% across regions. In regions with high PSA testing the difference in testing according to income was not smaller than in regions with little testing. PSA testing was higher among men aged 80-90 years (22%) than among men aged 50-59 years (13%). CONCLUSIONS: Men in the highest income group underwent PSA testing more frequently, and many older men were tested despite guideline recommendations to the contrary. This pattern of opportunistic, unstructured testing not only leads to inequity but also high rates of testing in men at greatest risk of harm and least likely to benefit. These findings underscore the need for organised prostate cancer testing.

Authors

Institutions

Publication Details

Journal
British Journal of Urology
Published
2026-11-18
DOI
https://doi.org/10.1111/bju.70549
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prostate‐specific antigen testing by income, age, and region: a nationwide population‐based study

Pär E. Stattin, Ulf Strömberg, Marcus Westerberg, Ola Bratt et al.
British Journal of Urology
Prostate Cancer Diagnosis and Treatment
article

Prostate‐specific antigen testing by income, age, and region: a nationwide population‐based study

Pär E. Stattin, Ulf Strömberg, Marcus Westerberg, Ola Bratt, Hans Garmo, Eugenio Ventimiglia, Rolf Gedeborg, Armando Galdieri
article en

Abstract

OBJECTIVE: To assess prostate-specific antigen (PSA) testing according to income, age, and region of residence in Sweden. PATIENTS AND METHODS: We conducted a nationwide, population-based open cohort study of men aged 40-90 years in Sweden without a prior diagnosis of prostate cancer between 2000 and 2023. The proportion of men that underwent at least one PSA test between 1 January and 31 December was estimated each year overall and stratified by income (bottom 25%, middle 50%, top 25%), age, and region of residence. RESULTS: The PSA testing was higher in the top income group across all ages. In 2019, prior to the coronavirus disease 2019 pandemic, overall PSA testing was 17% and ranged from 13% in the bottom income group to 20% in the top. Overall, PSA testing and income-related differences in PSA testing varied substantially between regions. In 2019, PSA testing varied between 12% and 20% between regions and difference in PSA testing between men with lowest and highest income ranged from 3.6% to 10% across regions. In regions with high PSA testing the difference in testing according to income was not smaller than in regions with little testing. PSA testing was higher among men aged 80-90 years (22%) than among men aged 50-59 years (13%). CONCLUSIONS: Men in the highest income group underwent PSA testing more frequently, and many older men were tested despite guideline recommendations to the contrary. This pattern of opportunistic, unstructured testing not only leads to inequity but also high rates of testing in men at greatest risk of harm and least likely to benefit. These findings underscore the need for organised prostate cancer testing.

British Journal of Urology
Uppsala University (SE), Uppsala University Hospital (SE), Vita-Salute San Raffaele University (IT), Sahlgrenska University Hospital (SE), University of Gothenburg (SE)
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon